undamentalytics Newsletter
Sign in

Iridex Corp cash flow statement

In fiscal 2025, Iridex Corp's operations generated −$2.1m of cash; it spent $143,000 on capital projects, leaving free cash flow of −$2.3m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Jan 20102010Jan 20112011Dec 20112012Dec 20122013Dec 20132014Jan 20152015Jan 20162016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Jan 20212021Jan 20222022Dec 20222023Dec 20232024Dec 20242025Jan 2026LTMJul 2026
Cash from operations312−114−1−0−4−10−8−38−10−7−7−2−2
Depreciation and amortisation000000111111101110
Stock-based pay000011122221222111
Capital spending000001111000000000
Free cash flow312−203−1−1−4−10−8−38−10−7−7−2−2
Free cash flow after stock pay302−2−02−2−3−6−12−10−46−11−9−9−3−3
Share buybacks00130520——————————
Shares issued———————15210——100————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: IRIX vs SENSAPYX vs IRIXCLPT vs IRIX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Iridex Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Iridex Corp.